Table 2.
Parameters | Subjects without ED | Subjects with ED | p value* |
---|---|---|---|
Subjects | 46 (42.6) | 62 (57.4) | |
Age | 0.001 | ||
Q1 ≤ 47 years | 15 (65.2) | 8 (34.8) | |
48 ≤ Q2 ≤ 53 years | 17 (50.0) | 17 (50.0) | |
54 ≤ Q3 ≤ 57 years | 8 (38.1) | 13 (61.9) | |
58 ≤ Q4 years | 6 (20.0) | 24 (80.0) | |
Smoking | 0.130 | ||
Never | 4 (8.7) | 12 (19.4) | |
Smoker | 25 (54.3) | 23 (37.1) | |
Ex-smoker | 17 (37.0) | 27 (43.5) | |
Metabolic factors | |||
BP ≥130/85 mm Hg or drugs | 28 (60.9) | 39 (62.9) | 0.829 |
WC ≥90 cm | 27 (58.7) | 30 (48.4) | 0.289 |
FBG ≥100 mg/dL or drugs | 13 (28.3) | 30 (48.4) | 0.035 |
TG ≥150 mg/dL or drugs | 22 (47.8) | 23 (37.1) | 0.263 |
HDL-C <40 mg/dL or drugs | 13 (28.3) | 18 (29.0) | 0.930 |
Metabolic syndrome | 21 (45.7) | 28 (45.2) | 0.960 |
TC/HDL-C >3.5 | 41 (89.1) | 48 (77.4) | 0.114 |
HOMA-IR ≥2.34 | 5 (10.9) | 10 (16.1) | 0.434 |
Data are presented as n (%). BP, blood pressure; WC, waist circumference; FBG, fasting blood glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment index-insulin resistance.
By χ2 test or linear by linear association.